Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6540
    +0.0017 (+0.26%)
     
  • OIL

    84.03
    +0.46 (+0.55%)
     
  • GOLD

    2,352.50
    +10.00 (+0.43%)
     
  • Bitcoin AUD

    98,375.10
    +113.30 (+0.12%)
     
  • CMC Crypto 200

    1,390.77
    -5.76 (-0.41%)
     
  • AUD/EUR

    0.6091
    +0.0018 (+0.30%)
     
  • AUD/NZD

    1.0976
    +0.0019 (+0.17%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    0.00 (0.00%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,670.50
    +385.96 (+2.23%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?

Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?

Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.